Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 34.14%1.45B | 53.91%6.15B | 51.09%4.14B | 37.98%2.44B | 26.65%1.08B | 30.23%4B | 24.06%2.74B | 23.71%1.76B | 25.11%853.99M | -23.09%3.07B |
Refunds of taxes and levies | 19.09%76.17M | 85.05%359.47M | 124.45%274.56M | 114.48%142.13M | 139.09%63.96M | 53.26%194.26M | 19.18%122.33M | 3.98%66.27M | -5.85%26.75M | -33.32%126.75M |
Cash received relating to other operating activities | -35.78%21.28M | 22.39%95.76M | 16.24%69.53M | 45.62%46.74M | 60.23%33.14M | 96.41%78.24M | 230.52%59.81M | 122.21%32.1M | 243.63%20.68M | -10.57%39.84M |
Cash inflows from operating activities | 31.36%1.55B | 54.75%6.61B | 53.44%4.49B | 40.84%2.62B | 30.76%1.18B | 31.95%4.27B | 25.45%2.92B | 23.82%1.86B | 25.72%901.43M | -23.42%3.24B |
Goods services cash paid | 52.29%978.04M | 104.59%4.88B | 103.34%3.34B | 77.51%1.58B | 67.83%642.23M | 35.56%2.38B | 24.56%1.64B | 8.57%889.77M | -7.54%382.68M | -35.86%1.76B |
Staff behalf paid | 46.12%290.18M | 44.44%687.95M | 50.31%543.41M | 36.07%333.38M | 37.52%198.59M | 21.63%476.29M | 16.72%361.51M | 16.88%245.01M | 14.47%144.41M | -4.50%391.58M |
All taxes paid | -4.77%149.92M | 42.70%729.16M | 45.56%490.95M | 45.25%311.75M | 60.48%157.43M | 26.57%510.97M | 22.65%337.28M | 16.82%214.62M | 13.28%98.1M | -10.67%403.71M |
Cash paid relating to other operating activities | 70.53%139.59M | 123.77%783.65M | 145.66%599.22M | 85.19%289.95M | 12.51%81.86M | 32.20%350.21M | 25.74%243.92M | 18.49%156.57M | 17.83%72.76M | -28.37%264.92M |
Cash outflows from operating activities | 44.22%1.56B | 90.20%7.08B | 92.38%4.97B | 66.97%2.51B | 54.76%1.08B | 32.02%3.72B | 23.26%2.59B | 11.97%1.51B | 1.39%697.94M | -29.06%2.82B |
Net cash flows from operating activities | -109.51%-9.38M | -185.25%-468.54M | -242.87%-485.3M | -69.32%109.61M | -51.55%98.59M | 31.47%549.61M | 45.04%339.68M | 123.66%357.24M | 610.22%203.49M | 65.02%418.06M |
Investing cash flow | ||||||||||
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --772.85 | ---- | ---- | ---- | ---- | ---- | --5.41K | ---- | ---- | ---- |
Cash received relating to other investing activities | 16.08%522.63M | 14.49%2.91B | -17.28%2.14B | -18.78%1.44B | 8.82%450.23M | 41.99%2.54B | 179.77%2.58B | 180.43%1.78B | 61.19%413.73M | 602.05%1.79B |
Cash inflows from investing activities | 16.08%522.63M | 14.49%2.91B | -17.28%2.14B | -18.78%1.44B | 8.82%450.23M | 41.99%2.54B | 179.77%2.58B | 180.43%1.78B | 61.19%413.73M | 601.23%1.79B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 294.41%30.3M | 271.47%92.82M | 160.33%45.69M | 199.22%31.45M | 85.49%7.68M | -30.51%24.99M | -22.55%17.55M | -15.09%10.51M | -48.67%4.14M | -59.09%35.96M |
Cash paid to acquire investments | -76.24%12.5M | 275.96%150.38M | --90.1M | --52.6M | --52.6M | 300.00%40M | ---- | ---- | ---- | --10M |
Cash paid relating to other investing activities | -22.25%690.06M | -40.24%2.17B | -49.72%1.89B | -26.67%1.73B | 20.64%887.49M | 103.44%3.64B | 224.48%3.76B | 271.83%2.36B | 188.48%735.63M | 609.70%1.79B |
Cash outflows from investing activities | -22.68%732.86M | -34.72%2.42B | -46.36%2.03B | -23.45%1.82B | 28.12%947.78M | 101.89%3.7B | 217.06%3.78B | 260.78%2.37B | 170.91%739.77M | 439.67%1.83B |
Net cash flows from investing activities | 57.75%-210.23M | 141.99%488.88M | 109.35%111.48M | 37.41%-372.49M | -52.60%-497.55M | -2,404.36%-1.16B | -345.75%-1.19B | -2,404.49%-595.14M | -1,888.57%-326.04M | 45.25%-46.49M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | --759.9M | --759.9M | ---- | ---- | ---- |
Cash from borrowing | 74.23%235.22M | 389.22%1.03B | 381.66%846.8M | 468.24%378.07M | --135M | 1,085.71%211.46M | --175.81M | --66.53M | ---- | 175.41%17.83M |
Cash received relating to other financing activities | 3.98%22.98M | -0.68%62.73M | --32.03M | --22.1M | --22.1M | 3,666.60%63.16M | ---- | ---- | ---- | -6.85%1.68M |
Cash inflows from financing activities | 64.35%258.2M | 6.06%1.1B | -6.08%878.83M | 501.46%400.17M | --157.1M | 5,202.30%1.03B | 55,704.62%935.7M | 3,867.99%66.53M | ---- | 135.77%19.51M |
Borrowing repayment | 1,843.96%194.4M | 349.94%538.47M | 1,157.21%226.17M | --155.34M | --10M | --119.68M | --17.99M | ---- | ---- | ---- |
Dividend interest payment | 464.79%3.48M | 123.37%227.02M | 30,011.50%165.26M | 25,984.31%85.82M | --615.74K | 195,556.64%101.63M | --548.84K | --328.99K | ---- | -74.99%51.94K |
Cash payments relating to other financing activities | 61.71%43.19M | 8.87%220.43M | -6.35%94.04M | 56.51%63.17M | -20.33%26.71M | 144.57%202.47M | 91.98%100.41M | 15.67%40.36M | 30.59%33.52M | -14.32%82.79M |
Cash outflows from financing activities | 545.86%241.07M | 132.65%985.92M | 308.12%485.47M | 647.84%304.33M | 11.34%37.32M | 411.57%423.78M | 127.42%118.95M | 16.62%40.69M | 30.59%33.52M | -29.98%82.84M |
Net cash flows from financing activities | -85.70%17.13M | -81.78%111.29M | -51.84%393.37M | 270.94%95.85M | 457.29%119.78M | 1,064.40%610.73M | 1,713.25%816.75M | 177.79%25.84M | -30.59%-33.52M | 42.45%-63.33M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -24.71%144.52K | -23.86%3.83M | -187.21%-3.28M | -47.07%1.59M | 122.42%191.96K | -58.45%5.04M | -69.62%3.76M | -64.59%3.01M | -44.35%-856.2K | 300.07%12.12M |
Net increase in cash and cash equivalents | 27.48%-202.33M | 12,063.88%135.47M | 149.71%16.27M | 20.86%-165.44M | -77.77%-278.99M | -99.65%1.11M | 54.34%-32.72M | -287.94%-209.05M | -1,020.18%-156.94M | 512.17%320.36M |
Add:Begin period cash and cash equivalents | 19.20%840.91M | 0.16%705.44M | 0.16%705.44M | 0.16%705.44M | 0.16%705.44M | 83.44%704.32M | 83.44%704.32M | 83.44%704.32M | 83.44%704.32M | 15.78%383.96M |
End period cash equivalent | 49.74%638.58M | 19.20%840.91M | 7.46%721.7M | 9.03%540M | -22.09%426.45M | 0.16%705.44M | 115.05%671.61M | 0.02%495.27M | 47.96%547.38M | 83.44%704.32M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.